Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Hypothalamic-pituitary function following childhood brain tumors: Analysis of prospective annual endocrine screening.

Lawson SA, Horne VE, Golekoh MC, Hornung L, Burns KC, Fouladi M, Rose SR.

Pediatr Blood Cancer. 2019 May;66(5):e27631. doi: 10.1002/pbc.27631. Epub 2019 Jan 28.

PMID:
30693650
2.

Hypothalamic Obesity: 4 Years of the International Registry of Hypothalamic Obesity Disorders.

Rose SR, Horne VE, Bingham N, Jenkins T, Black J, Inge T.

Obesity (Silver Spring). 2018 Nov;26(11):1727-1732. doi: 10.1002/oby.22315. Epub 2018 Oct 8.

PMID:
30296362
3.

Case Definitions for Conditions Identified by Newborn Screening Public Health Surveillance.

Sontag MK, Sarkar D, Comeau AM, Hassell K, Botto LD, Parad R, Rose SR, Wintergerst KA, Smith-Whitley K, Singh S, Yusuf C, Ojodu J, Copeland S, Hinton CF.

Int J Neonatal Screen. 2018;4(2):16. doi: 10.3390/ijns4020016. Epub 2018 May 9.

4.

Perinatal Endocrine Challenges.

Muir AB, Rose SR.

Clin Perinatol. 2018 Mar;45(1):xvii-xviii. doi: 10.1016/j.clp.2017.11.004. Epub 2017 Dec 1. No abstract available.

PMID:
29406016
5.

Use of Glucocorticoids for the Fetus and Preterm Infant.

Scott SM, Rose SR.

Clin Perinatol. 2018 Mar;45(1):93-102. doi: 10.1016/j.clp.2017.11.002. Epub 2017 Dec 26. Review.

PMID:
29406009
6.

Late endocrine effects of childhood cancer.

Rose SR, Horne VE, Howell J, Lawson SA, Rutter MM, Trotman GE, Corathers SD.

Nat Rev Endocrinol. 2016 Jun;12(6):319-36. doi: 10.1038/nrendo.2016.45. Epub 2016 Apr 1. Review.

PMID:
27032982
7.

Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study.

Rose SR, Reeves G, Gut R, Germak J.

J Pediatr. 2015 Dec;167(6):1389-96. doi: 10.1016/j.jpeds.2015.08.036. Epub 2015 Sep 26.

8.

Update of Endocrine Dysfunction following Pediatric Traumatic Brain Injury.

Reifschneider K, Auble BA, Rose SR.

J Clin Med. 2015 Jul 31;4(8):1536-60. doi: 10.3390/jcm4081536. Review.

9.

Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus.

Brunner HI, Silva CA, Reiff A, Higgins GC, Imundo L, Williams CB, Wallace CA, Aikawa NE, Nelson S, Klein-Gitelman MS, Rose SR.

Arthritis Rheumatol. 2015 May;67(5):1377-85. doi: 10.1002/art.39024.

10.

Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae.

Gass D, Dewire M, Chow L, Rose SR, Lawson S, Stevenson C, Pai AL, Jones B, Sutton M, Lane A, Pruitt D, Fouladi M, Hummel TR.

J Neurooncol. 2015 Mar;122(1):169-77. doi: 10.1007/s11060-014-1700-2. Epub 2015 Jan 13.

PMID:
25582835
11.

Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.

Petryk A, Kanakatti Shankar R, Giri N, Hollenberg AN, Rutter MM, Nathan B, Lodish M, Alter BP, Stratakis CA, Rose SR.

J Clin Endocrinol Metab. 2015 Mar;100(3):803-11. doi: 10.1210/jc.2014-4357. Epub 2015 Jan 9. Review.

12.

Growth hormone improves short stature in children with Diamond-Blackfan anemia.

Howell JC, Joshi SA, Hornung L, Khoury J, Harris RE, Rose SR.

Pediatr Blood Cancer. 2015 Mar;62(3):402-8. doi: 10.1002/pbc.25341. Epub 2014 Dec 9.

PMID:
25492299
13.

Hypopituitarism in pediatric survivors of inflicted traumatic brain injury.

Auble BA, Bollepalli S, Makoroff K, Weis T, Khoury J, Colliers T, Rose SR.

J Neurotrauma. 2014 Feb 15;31(4):321-6. doi: 10.1089/neu.2013.2916. Epub 2013 Nov 23.

14.

Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.

Rose SR, Kim MO, Korbee L, Wilson KA, Ris MD, Eyal O, Sherafat-Kazemzadeh R, Bollepalli S, Harris R, Jeng MR, Williams DA, Smith FO.

Pediatr Blood Cancer. 2014 Jan;61(1):11-9. doi: 10.1002/pbc.24617. Epub 2013 Sep 9. Erratum in: Pediatr Blood Cancer. 2014 May;61(5):957.

PMID:
24019220
15.

Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome gene mutations and Shwachman-Diamond syndrome.

Myers KC, Rose SR, Rutter MM, Mehta PA, Khoury JC, Cole T, Harris RE.

J Pediatr. 2013 Jun;162(6):1235-40, 1240.e1. doi: 10.1016/j.jpeds.2012.11.062. Epub 2013 Jan 8.

16.

Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure.

Rutter MM, Collins J, Rose SR, Woo JG, Sucharew H, Sawnani H, Hor KN, Cripe LH, Wong BL.

Neuromuscul Disord. 2012 Dec;22(12):1046-56. doi: 10.1016/j.nmd.2012.07.009. Epub 2012 Sep 8.

PMID:
22967789
17.

Bariatric surgery in hypothalamic obesity.

Bingham NC, Rose SR, Inge TH.

Front Endocrinol (Lausanne). 2012 Feb 14;3:23. doi: 10.3389/fendo.2012.00023. eCollection 2012.

18.

Fanconi anemia links reactive oxygen species to insulin resistance and obesity.

Li J, Sipple J, Maynard S, Mehta PA, Rose SR, Davies SM, Pang Q.

Antioxid Redox Signal. 2012 Oct 15;17(8):1083-98. doi: 10.1089/ars.2011.4417. Epub 2012 Jun 25.

19.

Absence of mutation in coding regions of CYP2R1 gene in apparent autosomal dominant vitamin D 25-hydroxylase deficiency rickets.

Tosson H, Rose SR.

J Clin Endocrinol Metab. 2012 May;97(5):E796-801. doi: 10.1210/jc.2011-2716. Epub 2012 Mar 14.

PMID:
22419701
20.

Endocrine phenotype of children and adults with Fanconi anemia.

Rose SR, Myers KC, Rutter MM, Mueller R, Khoury JC, Mehta PA, Harris RE, Davies SM.

Pediatr Blood Cancer. 2012 Oct;59(4):690-6. doi: 10.1002/pbc.24095. Epub 2012 Jan 31.

PMID:
22294495

Supplemental Content

Loading ...
Support Center